{"id":714493,"date":"2022-11-22T16:45:35","date_gmt":"2022-11-22T21:45:35","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/dbv-technologies-to-participate-in-upcoming-investor-conference\/"},"modified":"2022-11-22T16:45:35","modified_gmt":"2022-11-22T21:45:35","slug":"dbv-technologies-to-participate-in-upcoming-investor-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/dbv-technologies-to-participate-in-upcoming-investor-conference\/","title":{"rendered":"DBV Technologies to Participate in Upcoming Investor Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">Montrouge, France, November 22, 2022<\/p>\n<p align=\"left\">\n        <strong>DBV Technologies <\/strong><br \/>\n        <strong>t<\/strong><br \/>\n        <strong>o Participate <\/strong><br \/>\n        <strong>i<\/strong><br \/>\n        <strong>n Upcoming Investor Conference<\/strong>\n      <\/p>\n<p align=\"justify\">DBV Technologies (Euronext: DBV \u2013 ISIN: FR0010417345 \u2013 Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced its participation in the 5th Annual Evercore ISI HealthCONx Conference taking place Nov. 29 \u2013 Dec. 1, 2022. Daniel Tass\u00e9, Chief Executive Officer, will participate in a Fireside Chat session on Wednesday, Nov. 30, at 8 a.m. ET, as well as one-on-one investor meetings throughout the day.<\/p>\n<p align=\"justify\">A live webcast of the fireside chat will be available on the Investors &amp; Media section of the Company\u2019s website: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4ce1mqLr2y6VIsEJC1z_lJlaJMoF6ZJtocKld-qioV8nY38lr5odjoBJxlDZELv2oJhB5YP4190btcDHKGeqC6PbAgYcwPeltJujEmc_Wxa6CEnNwF1TZn8zwJpa7-dDr1tyGB6Jn-Kmuk47Rwey2scjswnDfouQbDEeYPi9tMtZ_PlyITRys-DgNOJ4pzH3rn3si61_FLtXubcRC4bVyMDCJUm6mUUFsLeHzz-x2wPTWz4-OQX0TmiwM1Exnjp-15xruh9xrAX11HpVvJQHEjm1rhO5S-SgOUj157UR67RpfzYRI0uS5NPvccXqoI_d_2j35jQfRie3vue_qq6WEWh973UtHSBosUWF7kJuWM-IypfoxruDD9zHlubLFbGEXOtafVmSgKXIdhprMyuQsA0YpY15V-NjjzBOpmT4ND4U-y3v7XrNnGt8r1Zcodiub1Ym4D-oGB5E3keIw1N4lPnZXhlyeCywOSEnmrJVaRyOX_kPm67yYhUnbqA3AlIsSPjuhAm2n-EVu6XHaND9fLCP8Vnqek2Im0CoMfaOynva18hxBddiFiPwcPO1oFmAl9TXCdfRWBqXN307LiAqQMNMLRk_2pzzInkcBVA_d8wsHAKp5cz3fRcsmbb8Dvn-ptWCINY4ra_-tAEBa66MzQuTRjhbTiBD5MDu2xBAmg7zAvvsZyL5G7vDXnBUOfGVj-cPQpQC1tN0PuzqUckQbqM3kEx36roEuQbaPSjNqbbqicvY-QfF0sQcMMqHVMYV5x-B1v35klNR60CW1Aoau2DTfETX96txB93XFGfxkfuWW3qgQpN5WOnHTn-GhWKb49rahkFee8VSPKVwj5JPwaoTj9_nR6AT8yEoT766VILgrAM2iiKk8cciAi0X2_0ScOZf2IzjgSKpHWueTROrFemF-iUZvdKpCfZpnk-fGKWaSGUf5ui7Kl4tSRK0LKGB\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/wsw.com\/webcast\/evercore29\/dbvt\/2371680<\/a>.<\/p>\n<p align=\"justify\">A replay will also be available on DBV Technologies\u2019 website for 90 days after the event.<\/p>\n<p align=\"justify\">\n        <strong>About DBV Technologies<\/strong><br \/>\n        <br \/>DBV Technologies is developing Viaskin\u2122, an investigational proprietary technology platform with broad potential applications in immunotherapy. Viaskin is based on epicutaneous immunotherapy, or EPIT\u2122, and is DBV Technologies\u2019 method of delivering biologically active compounds to the immune system through intact skin. With this new class of non-invasive product candidates, the Company is dedicated to safely transforming the care of food allergic patients. DBV Technologies\u2019 food allergies programs include ongoing clinical trials of Viaskin Peanut. DBV Technologies has global headquarters in Montrouge, France, and North American operations in Basking Ridge, NJ. The Company\u2019s ordinary shares are traded on segment B of Euronext Paris (Ticker: DBV, ISIN code: FR0010417345) and the Company\u2019s ADSs (each representing one-half of one ordinary share) are traded on the Nasdaq Global Select Market (Ticker: DBVT).<\/p>\n<p align=\"justify\">\n        <strong>Investor <\/strong><br \/>\n        <strong>Contact<\/strong><br \/>\n        <br \/>Anne Pollak<br \/>DBV Technologies<br \/>+1 857-529-2363<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=360lhJgJxSwDIAv-9QaswXg3noPB0nSPYY06yXdPFf52G_16ecIBcGrBPvYHd-3MZm_Hwp8td-CXnaEmcxnKv0Hvt4RC5SNxzLpka0rCaFJjaHbHyC7zf2sY9BSBvdkM\" rel=\"nofollow noopener\" target=\"_blank\">anne.pollak@dbv-technologies.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Angela Marcucci<br \/>DBV Technologies<br \/>+1 646-842-2393<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fuv2k6T2BvPEaNiVCmXVtV5C39s5vyB2Xrj8y2DtDtnfuHqaHAUSxT-FV3XgUTGWTd3NcHZXzucjEKe-zDJe9mYrMP5v8beArpzriE-1PGmTWm5X4i-Inoo1HmcAj-lFxuUmcKBjh5CWzJCqoOUn9w==\" rel=\"nofollow noopener\" target=\"_blank\">angela.marcucci@dbv-technologies.com<\/a>\u00a0<\/p>\n<p align=\"justify\">Viaskin and EPIT are trademarks of DBV Technologies.<\/p>\n<\/p>\n<p id=\"gnw_attachments_section-header\">\n        <strong>Attachment<\/strong>\n      <\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n          <a target=\"_blank\" href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/5a035ca0-c3c1-4cee-9496-131212b1fc63\" rel=\"noopener\">PDF Version<\/a>\n        <\/li>\n<\/ul>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc2ODM0MSM0MDE0MzMwMzAjMTAxMTE1Mg==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/MDBiZTNkNmUtYmE3My00OGQ1LTg0YTctZDQ0YmEwZDYxMWMzLTEwMTExNTI=\/tiny\/DBV-Technologies-S-A-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Montrouge, France, November 22, 2022 DBV Technologies t o Participate i n Upcoming Investor Conference DBV Technologies (Euronext: DBV \u2013 ISIN: FR0010417345 \u2013 Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced its participation in the 5th Annual Evercore ISI HealthCONx Conference taking place Nov. 29 \u2013 Dec. 1, 2022. Daniel Tass\u00e9, Chief Executive Officer, will participate in a Fireside Chat session on Wednesday, Nov. 30, at 8 a.m. ET, as well as one-on-one investor meetings throughout the day. A live webcast of the fireside chat will be available on the Investors &amp; Media section of the Company\u2019s website: https:\/\/wsw.com\/webcast\/evercore29\/dbvt\/2371680. A replay will also be available on DBV Technologies\u2019 website for 90 days after the event. About DBV Technologies &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dbv-technologies-to-participate-in-upcoming-investor-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;DBV Technologies to Participate in Upcoming Investor Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-714493","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>DBV Technologies to Participate in Upcoming Investor Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dbv-technologies-to-participate-in-upcoming-investor-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DBV Technologies to Participate in Upcoming Investor Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Montrouge, France, November 22, 2022 DBV Technologies t o Participate i n Upcoming Investor Conference DBV Technologies (Euronext: DBV \u2013 ISIN: FR0010417345 \u2013 Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced its participation in the 5th Annual Evercore ISI HealthCONx Conference taking place Nov. 29 \u2013 Dec. 1, 2022. Daniel Tass\u00e9, Chief Executive Officer, will participate in a Fireside Chat session on Wednesday, Nov. 30, at 8 a.m. ET, as well as one-on-one investor meetings throughout the day. A live webcast of the fireside chat will be available on the Investors &amp; Media section of the Company\u2019s website: https:\/\/wsw.com\/webcast\/evercore29\/dbvt\/2371680. A replay will also be available on DBV Technologies\u2019 website for 90 days after the event. About DBV Technologies &hellip; Continue reading &quot;DBV Technologies to Participate in Upcoming Investor Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/dbv-technologies-to-participate-in-upcoming-investor-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-22T21:45:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc2ODM0MSM0MDE0MzMwMzAjMTAxMTE1Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dbv-technologies-to-participate-in-upcoming-investor-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dbv-technologies-to-participate-in-upcoming-investor-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"DBV Technologies to Participate in Upcoming Investor Conference\",\"datePublished\":\"2022-11-22T21:45:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dbv-technologies-to-participate-in-upcoming-investor-conference\\\/\"},\"wordCount\":287,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dbv-technologies-to-participate-in-upcoming-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDc2ODM0MSM0MDE0MzMwMzAjMTAxMTE1Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dbv-technologies-to-participate-in-upcoming-investor-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dbv-technologies-to-participate-in-upcoming-investor-conference\\\/\",\"name\":\"DBV Technologies to Participate in Upcoming Investor Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dbv-technologies-to-participate-in-upcoming-investor-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dbv-technologies-to-participate-in-upcoming-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDc2ODM0MSM0MDE0MzMwMzAjMTAxMTE1Mg==\",\"datePublished\":\"2022-11-22T21:45:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dbv-technologies-to-participate-in-upcoming-investor-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dbv-technologies-to-participate-in-upcoming-investor-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dbv-technologies-to-participate-in-upcoming-investor-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDc2ODM0MSM0MDE0MzMwMzAjMTAxMTE1Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDc2ODM0MSM0MDE0MzMwMzAjMTAxMTE1Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dbv-technologies-to-participate-in-upcoming-investor-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DBV Technologies to Participate in Upcoming Investor Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DBV Technologies to Participate in Upcoming Investor Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/dbv-technologies-to-participate-in-upcoming-investor-conference\/","og_locale":"en_US","og_type":"article","og_title":"DBV Technologies to Participate in Upcoming Investor Conference - Market Newsdesk","og_description":"Montrouge, France, November 22, 2022 DBV Technologies t o Participate i n Upcoming Investor Conference DBV Technologies (Euronext: DBV \u2013 ISIN: FR0010417345 \u2013 Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced its participation in the 5th Annual Evercore ISI HealthCONx Conference taking place Nov. 29 \u2013 Dec. 1, 2022. Daniel Tass\u00e9, Chief Executive Officer, will participate in a Fireside Chat session on Wednesday, Nov. 30, at 8 a.m. ET, as well as one-on-one investor meetings throughout the day. A live webcast of the fireside chat will be available on the Investors &amp; Media section of the Company\u2019s website: https:\/\/wsw.com\/webcast\/evercore29\/dbvt\/2371680. A replay will also be available on DBV Technologies\u2019 website for 90 days after the event. About DBV Technologies &hellip; Continue reading \"DBV Technologies to Participate in Upcoming Investor Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/dbv-technologies-to-participate-in-upcoming-investor-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2022-11-22T21:45:35+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc2ODM0MSM0MDE0MzMwMzAjMTAxMTE1Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dbv-technologies-to-participate-in-upcoming-investor-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dbv-technologies-to-participate-in-upcoming-investor-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"DBV Technologies to Participate in Upcoming Investor Conference","datePublished":"2022-11-22T21:45:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dbv-technologies-to-participate-in-upcoming-investor-conference\/"},"wordCount":287,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dbv-technologies-to-participate-in-upcoming-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc2ODM0MSM0MDE0MzMwMzAjMTAxMTE1Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dbv-technologies-to-participate-in-upcoming-investor-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/dbv-technologies-to-participate-in-upcoming-investor-conference\/","name":"DBV Technologies to Participate in Upcoming Investor Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dbv-technologies-to-participate-in-upcoming-investor-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dbv-technologies-to-participate-in-upcoming-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc2ODM0MSM0MDE0MzMwMzAjMTAxMTE1Mg==","datePublished":"2022-11-22T21:45:35+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dbv-technologies-to-participate-in-upcoming-investor-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/dbv-technologies-to-participate-in-upcoming-investor-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dbv-technologies-to-participate-in-upcoming-investor-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc2ODM0MSM0MDE0MzMwMzAjMTAxMTE1Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDc2ODM0MSM0MDE0MzMwMzAjMTAxMTE1Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dbv-technologies-to-participate-in-upcoming-investor-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"DBV Technologies to Participate in Upcoming Investor Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/714493","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=714493"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/714493\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=714493"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=714493"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=714493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}